Xvivo System model X2 —  The 21st Century GMP Quality Platform for processing and producing clinical grade cells.

  • All
  • Testimonials
  • Uncategorized
May 7, 2019
Point-of-Use Inoculum Prep
April 22, 2019
ISPE 2019: Closing Down the Process – The Future of Cell and Gene Therapy Manufacturing
November 21, 2018
Advanced Regenerative Manufacturing Institute (ARMI) New Member Spotlight
October 23, 2018
BioSpherix Medical Chosen by ACF Bioservices™
October 19, 2018
Cleanrooms West and BioSpherix Medical Collaboration
October 17, 2018
Hodess Cleanrooms Installs GMP Isolator Into Wall
October 11, 2018
Testimonial: Bristol-Myers Squibb
October 4, 2018
BioSpherix Announces Facility and Capacity Expansion
August 3, 2018
BioSpherix seen on National Geographic: Miracle Hospital
July 18, 2018
Could reducing cell manufacturing fluctuations help customers like Novartis improve their cell variability issues for Kymriah?
July 12, 2018
Institute for Vision Research Announces a Culture System for Human Donor Retina
June 20, 2018
BioSpherix Sponsors the 2018 ISSCR Meeting in Melbourne!
May 16, 2018
BioSpherix Medical at ASGCT
May 8, 2018
BioSpherix Medical at ISCT in Montreal
April 30, 2018
BioSpherix Medical Announces Successful Completion of F.A.T. Test
April 17, 2018
BioSpherix Medical will be attending Interphex in NYC
March 12, 2018
Death to Cleanrooms!
February 27, 2018
A Short guide to Cell Therapy Manufacturing, Pt. 2
February 1, 2018
BioSpherix Medical Announces New Partnership
January 26, 2018
Phacilitate Cell & Gene Therapy conference + World Stem Cell Summit
December 20, 2017
A Short guide to Cell Therapy Manufacturing, Pt. 1
November 1, 2017
BioSpherix Medical Named Supplier of Choice for Semma Therapeutics
September 1, 2017
TISCH MS Center of NY Announces new Institute for Regenerative Cell Therapy
January 1, 2017
Weill Cornell Announces New cGMP Cellular Therapy Manufacturing Facility